How can we unleash the potential of external controls in clinical trials?
Drug Discov Today
.
2023 Apr;28(4):103492.
doi: 10.1016/j.drudis.2023.103492.
Epub 2023 Jan 18.
Authors
Philipp Schwarz
1
,
Ekkehard Brockstedt
2
Affiliations
1
BI X GmbH, Binger Str. 173, 55216 Ingelheim am Rhein, Germany.
2
Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216 Ingelheim am Rhein, Germany. Electronic address: ekkehard.brockstedt@boehringer-ingelheim.com.
PMID:
36681236
DOI:
10.1016/j.drudis.2023.103492
No abstract available
Publication types
Editorial
MeSH terms
Clinical Trials as Topic* / standards
Control Groups